Biogen Stock Analysis

BIIB -  USA Stock  

USD 383.08  8.23  2.10%

The current price rise of Biogen Inc could raise concerns from investors as the firm it trading at a share price of 383.08 on 848,088 in volume. The company executives may have good odds in positioning the firm resources to exploit market volatility in July. The stock standard deviation of daily returns for 90 days investing horizon is currently 5.12. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Biogen partners.
Continue to Trending Equities.

Search Stock Analysis 

 
Refresh
The Biogen stock analysis report makes it easy to digest most publicly released information about Biogen and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Biogen stock analysis module also helps to analyze the Biogen price relationship with some important fundamental indicators such as market cap and management efficiency.

Biogen Stock Analysis Notes

About 88.0% of the company shares are held by institutions such as insurance companies. The company recorded earning per share (EPS) of 19.29. Biogen Inc had not issued any dividends in recent years. The entity had 3:1 split on the 18th of January 2001. Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases worldwide. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts. Biogen operates under Drug ManufacturersGeneral classification in the United States and is traded on NASDAQ Exchange. It employs 9100 people. For more info on Biogen Inc please contact George Scangos at 617 679-2000 or go to www.biogen.com.

Biogen Quarterly Cost of Revenue

478.1 MillionShare

Biogen Inc Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Biogen's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Biogen Inc or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Biogen Inc is way too risky over 90 days horizon
Biogen Inc appears to be risky and price may revert if volatility continues
Over 88.0% of the company shares are held by institutions such as insurance companies
Latest headline from www.bloomberg.com: Biotech Stocks Fall After Sage-Biogen Depression Drug Misses Mark - Bloomberg

Biogen Inc Upcoming and Recent Events

Earnings reports are used by Biogen to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Biogen previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report28th of July 2021
Next Earnings Report20th of October 2021
Next Fiscal Quarter End30th of June 2021
Next Fiscal Year End2nd of February 2022
Last Quarter Report31st of March 2021
Last Earning Announcement30th of June 2020

Biogen Largest EPS Surprises

Earnings surprises can significantly impact Biogen's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2000-07-18
2000-06-300.080.090.0112 
1999-04-20
1999-03-310.030.040.0133 
1999-02-09
1998-12-310.040.050.0125 
View All Earnings Estimates

Biogen SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Biogen prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Biogen investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Biogen Inc specific information freely available to individual and institutional investors to make a timely investment decision.
8th of June 2021
Financial Statements and Exhibits. Submission of Matters to a Vote of Security Holders. Amendments to Articles of Incorporation or Bylaws; and/or Change in Fiscal Year
View
22nd of April 2021
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
9th of April 2021
Financial Statements and Exhibits. Other Events. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View
16th of February 2021
Financial Statements and Exhibits. Other Events
View
12th of February 2021
Unclassified Corporate Event
View
10th of February 2021
Unclassified Corporate Event
View
4th of February 2021
Financial Statements and Exhibits. Other Events
View
3rd of February 2021
Financial Statements and Exhibits. Results of Operations and Financial Condition
View

Biogen Thematic Classifications

In addition to having Biogen stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.

Biogen Market Capitalization

The company currently falls under 'Large-Cap' category with current market capitalization of 59.72 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Biogen's market, we take the total number of its shares issued and multiply it by Biogen's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Biogen Profitablity

Biogen's profitability indicators refer to fundamental financial ratios that showcase Biogen's ability to generate income relative to its revenue or operating costs. If, let's say, Biogen is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Biogen's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Biogen's profitability requires more research than a typical breakdown of Biogen's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 23.89 %, which can signify that it executes well on its competitive strategies and has good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of 29.4 %, which suggests for every 100 dollars of sales, it generated a net operating income of 0.29.
Last ReportedProjected for 2021
Return on Investment 23.36  24.53 
Return on Average Assets 0.16  0.18 
Return on Average Equity 0.35  0.35 
Return on Invested Capital 0.28  0.31 
Return on Sales 0.37  0.42 

Management Efficiency

The entity has return on total asset (ROA) of 9.27 % which means that it generated profit of $9.27 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 26.49 %, meaning that it created $26.49 on every $100 dollars invested by stockholders. Biogen management efficiency ratios could be used to measure how well biogen inc manages its routine affairs as well as how well it operates its assets and liabilities. Biogen Return on Investment is projected to slightly grow based on the last few years of reporting. The past year's Return on Investment was at 23.36. The current year Return on Average Assets is expected to grow to 0.18, whereas Return on Average Equity is forecasted to decline to 0.35. Biogen Current Assets are projected to increase significantly based on the last few years of reporting. The past year's Current Assets were at 6.89 Billion. The current year Tax Assets is expected to grow to about 1.8 B, whereas Total Assets are forecasted to decline to about 23.3 B.
Last ReportedProjected for 2021
Book Value per Share 66.50  62.17 
Enterprise Value over EBIT 9.00  11.02 
Enterprise Value over EBITDA 7.65  9.38 
Price to Book Value 3.52  4.04 
Tangible Assets Book Value per Share 98.03  83.72 
Enterprise Value43.3 B54.3 B
Tangible Asset Value15.8 B15 B

Technical Drivers

As of the 17th of June 2021, Biogen shows the Risk Adjusted Performance of 0.0968, downside deviation of 1.68, and Mean Deviation of 2.0. Biogen Inc technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to collect and analyze data for nineteen technical drivers for Biogen Inc, which can be compared to its rivals. Please confirm Biogen Inc maximum drawdown, semi variance, and the relationship between the jensen alpha and potential upside to decide if Biogen Inc is priced correctly, providing market reflects its regular price of 383.08 per share. Given that Biogen has jensen alpha of 0.6989, we suggest you to validate Biogen Inc's prevailing market performance to make sure the company can sustain itself at a future point.

Biogen Inc Price Movement Analysis

The output start index for this execution was fourty-nine with a total number of output elements of twelve. The Exponential Moving Average is calculated by weighting recent values of Biogen Inc more heavily than older values. View also all equity analysis or get more info about exponential moving average overlap studies indicator.

Biogen Inc Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Biogen insiders, such as employees or executives, is commonly permitted as long as it does not rely on Biogen's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Biogen insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Biogen Outstanding Bonds

Biogen issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Biogen Inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Biogen bonds can be classified according to their maturity, which is the date when Biogen Inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
MaturityCouponRating
09062XAB9 6.875%03/01/20186.875
BBB

Biogen Predictive Daily Indicators

Biogen intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Biogen stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Biogen Forecast Models

Biogen time-series forecasting models is one of many Biogen's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Biogen's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Biogen Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Biogen stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Biogen shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Biogen. By using and applying Biogen Stock analysis, traders can create a robust methodology for identifying Biogen entry and exit points for their positions.
Last ReportedProjected for 2021
Operating Margin 32.51  33.61 
EBITDA Margin 0.42  0.49 
Gross Margin 0.87  0.82 
Profit Margin 0.30  0.33 
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases worldwide. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts. Biogen operates under Drug ManufacturersGeneral classification in the United States and is traded on NASDAQ Exchange. It employs 9100 people.

Current Biogen Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Biogen analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Biogen analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
399.81Hold27Odds
Biogen Inc current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Biogen analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Biogen stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Biogen Inc, talking to its executives and customers, or listening to Biogen conference calls.
Biogen Analyst Advice Details

Biogen Stock Analysis Indicators

Biogen Inc stock analysis indicators help investors evaluate how Biogen stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Biogen shares will generate the highest return on investment. By understating and applying Biogen stock analysis, traders can identify Biogen position entry and exit signals to maximize returns.
Quick Ratio1.50
Fifty Two Week Low223.25
Revenue Growth-23.80%
Shares Short Prior Month3.97M
Average Daily Volume Last 10 Day7.08M
Average Daily Volume In Three Month1.72M
Earnings Growth-66.70%
Shares Percent Shares Out2.15%
Earnings Quarterly Growth-70.70%
Gross Margins85.49%
Short Percent Of Float2.42%
Forward Price Earnings19.67
Float Shares149.51M
Fifty Two Week High468.55
Enterprise Value To Ebitda11.23
Fifty Day Average293.05
Two Hundred Day Average270.98
Enterprise Value To Revenue3.69
Continue to Trending Equities. Note that the Biogen Inc information on this page should be used as a complementary analysis to other Biogen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Valuation module to check real value of public entities based on technical and fundamental data.

Complementary Tools for Biogen Stock analysis

When running Biogen Inc stock analysis, check to measure Biogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biogen is operating at the current time. Most of Biogen's stock examination focuses on studying past and present price action to predict the probability of Biogen's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Biogen's price. Additionally, you may evaluate how the addition of Biogen to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
ETF Directory
Find actively-traded Exchange Traded Funds (ETF) from around the world
Go
The market value of Biogen Inc is measured differently than its book value, which is the value of Biogen that is recorded on the company's balance sheet. Investors also form their own opinion of Biogen stock's value that differs from its market value or its book value, called intrinsic value, which is Biogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biogen's market value can be influenced by many factors that don't directly affect Biogen Inc underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biogen's stock value and its price as these two are different measures arrived at by different means. Investors typically determine Biogen value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biogen's stock price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.